ABT-981

BIOLOGICAL3 trials

Sponsors

AbbVie (prior sponsor, Abbott), AbbVie

Conditions

Erosive Hand OsteoarthritisKnee OsteoarthritisMedial Compartment Knee OsteoarthritisOsteoarthritis

Phase 1

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-981 in Patients With Osteoarthritis of the Knee

CompletedNCT01668511

AbbVie (prior sponsor, Abbott)Osteoarthritis

Start: 2012-09-30End: 2013-10-31Updated: 2017-11-20

Phase 2

A Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients With Knee Osteoarthritis

CompletedNCT02087904

AbbVieKnee Osteoarthritis, Medial Compartment Knee Osteoarthritis

Start: 2014-06-04End: 2016-12-13Updated: 2019-08-28

A Phase 2a Study Evaluating the Safety and Efficacy of ABT-981 in Patients With Erosive Hand Osteoarthritis

CompletedNCT02384538

AbbVieErosive Hand Osteoarthritis

Start: 2015-03-31End: 2016-07-31Updated: 2017-08-11

Related Papers

Safety, tolerability, and pharmacodynamics of an anti-interleukin-1α/β dual variable domain immunoglobulin in patients with osteoarthritis of the knee: a randomized phase 1 study.

2017-09-2854 citations